Testing effectiveness (Phase 2)Study completedNCT05266014
What this trial is testing
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
Who this might be right for
Stargardt Disease
RBP4 Pty Ltd 13